ArticleFuture science OA2025
Mesenteric panniculitis: is it really associated with cancer? A retrospective imaging-based study.
Article in Future science OA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mesenteric Panniculitis in a Patient with Ulcerative Colitis in Remission on Vedolizumab Therapy: A Case Report and Literature Review.Journal of clinical medicine · 2026Review
- High Prevalence of MRI Features of Mesenteric Panniculitis in Chronic Intestinal Inflammation: A Retrospective 3-T MRI Study.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe link between mesenteric panniculitis (MP) and cancer is debated. We explored this association after adjusting for age. MATERIALS &
methodsWe retrospectively analyzed abdominal CT scans of 8,750 patients between 2015 and 2017. Patients were categorized by cancer status.
resultsOf included patients, 8.7% had cancer. MP was found in 148 patients (58% males, mean age 57.8 years). MP was more frequent in cancer patients (5.14%) compared to no-cancer group (1.36%). Among MP patients, breast cancer was the most common malignancy. After adjusting for age, MP remained significantly associated with breast cancer and multiple myeloma in females and lymphoma in males.
conclusionMP was significantly associated with breast cancer and multiple myeloma in females and lymphoma in males.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.